IBC Forms and Policies
Registration and Submission Forms
New IBC protocols and changes to existing IBC protocols are to be submitted via the electronic Institutional Biosafety Committee system, eIBC, and may require use of one or more of these forms.
This form should be used for new research projects involving non-recombinant infectious agents or biological toxins.
This form must be submitted to the eIBC for all non-exempt research involving rDNA or synthetic nucleic acid molecules.
This form is used if the project involves administration an investigational drug to human subjects that consists of recombinant DNA (rDNA), synthetic nucleic acid molecules, or an infectious agent, as defined in the Investigational Medication Dispensed to Research Subjects Policy.
Research Accidents and Spills
This policy describes the responsibilities and procedures for immediate response to accident and spills of biohazardous materials.
This form is for capturing necessary information about accidents and spills of biohazardous materials.
This FAQ provides some examples of research accidents and outlines whether or not they are reportable to the IBC.
Additional policies governing IBC review:
A full list of IBC policies is available here.
Viral vector system resources
Adenovirus PCR protocol for follow-up testing: Ad PCR
Protocol for RCV for murine retroviral vectors RCR
Provides biosafety guidelines for those working at Oregon Health & Science University (OHSU), including any work that involves the handling of infectious microorganisms, human or animal tissues or body fluids, or research animals with additional detail on their disposal provided in the
Additional detail related to high hazard biological toxins is provided in the
The IBC Form BSL2 Lab Checklist outlines basic requirements for Biosafety level 2 containment and practices.